Acino accepts $439 mln takeover offer from Avista Capital, Nordic Capital

Swiss generic drugmaker Acino said it has accepted a takeover offer from Avista Capital Partners and Nordic Capital valuing the company at about 398 million Swiss francs ($439 million), sister news service Reuters reported.